K
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Price:
3 185
KRW
1.11%
Market Cap:
₩159.8B
Income Statement
Earnings Waterfall
Kukjeon Pharmaceutical Co Ltd
Kukjeon Pharmaceutical Co Ltd
Income Statement
Kukjeon Pharmaceutical Co Ltd
Kukjeon Pharmaceutical Co Ltd
Currency: KRW
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Interest Expense |
48
|
63
|
65
|
67
|
68
|
576
|
134
|
203
|
241
|
284
|
240
|
216
|
518
|
1 802
|
3 033
|
4 252
|
5 206
|
5 735
|
6 411
|
7 071
|
8 002
|
8 220
|
7 773
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
80 623
N/A
|
98 765
+23%
|
120 429
+22%
|
142 158
+18%
|
85 354
-40%
|
92 528
+8%
|
97 094
+5%
|
102 731
+6%
|
103 711
+1%
|
110 274
+6%
|
113 905
+3%
|
116 685
+2%
|
121 998
+5%
|
129 429
+6%
|
133 272
+3%
|
134 441
+1%
|
136 468
+2%
|
135 442
-1%
|
135 077
0%
|
132 967
-2%
|
|
| Gross Profit | ||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
(66 105)
|
(80 181)
|
(96 909)
|
(114 475)
|
(67 409)
|
(73 076)
|
(77 696)
|
(83 551)
|
(84 195)
|
(89 032)
|
(90 739)
|
(91 055)
|
(96 721)
|
(104 529)
|
(109 128)
|
(111 949)
|
(114 594)
|
(115 377)
|
(116 214)
|
(114 875)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
14 518
N/A
|
18 584
+28%
|
23 520
+27%
|
27 683
+18%
|
17 946
-35%
|
19 452
+8%
|
19 398
0%
|
19 180
-1%
|
19 515
+2%
|
21 242
+9%
|
23 167
+9%
|
25 629
+11%
|
25 277
-1%
|
24 900
-1%
|
24 144
-3%
|
22 492
-7%
|
21 874
-3%
|
20 065
-8%
|
18 863
-6%
|
18 092
-4%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(44)
|
(38)
|
(39)
|
(66)
|
(65)
|
(8 728)
|
(11 109)
|
(13 835)
|
(16 719)
|
(11 811)
|
(12 968)
|
(13 816)
|
(15 195)
|
(16 006)
|
(17 117)
|
(17 652)
|
(18 552)
|
(18 778)
|
(19 485)
|
(20 967)
|
(20 551)
|
(21 505)
|
(21 189)
|
(21 206)
|
(22 466)
|
|
| Selling, General & Administrative |
(44)
|
(38)
|
(39)
|
(66)
|
(65)
|
(8 425)
|
(10 726)
|
(13 364)
|
(16 161)
|
(11 464)
|
(12 619)
|
(13 436)
|
(14 725)
|
(15 429)
|
(16 397)
|
(16 801)
|
(17 555)
|
(17 639)
|
(18 223)
|
(19 587)
|
(19 108)
|
(20 024)
|
(19 693)
|
(19 706)
|
(20 975)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(303)
|
(386)
|
(474)
|
(561)
|
(347)
|
(349)
|
(380)
|
(471)
|
(577)
|
(720)
|
(851)
|
(997)
|
(1 139)
|
(1 264)
|
(1 380)
|
(1 443)
|
(1 481)
|
(1 496)
|
(1 500)
|
(1 490)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(44)
N/A
|
(38)
+14%
|
(39)
-3%
|
(66)
-69%
|
(65)
+2%
|
5 790
N/A
|
7 476
+29%
|
9 685
+30%
|
10 964
+13%
|
6 135
-44%
|
6 484
+6%
|
5 582
-14%
|
3 985
-29%
|
3 509
-12%
|
4 126
+18%
|
5 515
+34%
|
7 077
+28%
|
6 499
-8%
|
5 414
-17%
|
3 177
-41%
|
1 941
-39%
|
368
-81%
|
(1 124)
N/A
|
(2 343)
-108%
|
(4 373)
-87%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
(11)
|
3
|
5
|
6
|
156
|
(519)
|
(686)
|
(833)
|
(1 480)
|
(1 028)
|
(1 045)
|
(916)
|
(2 188)
|
7 686
|
10 668
|
5 167
|
3 675
|
(4 834)
|
(8 039)
|
(889)
|
3 467
|
3 084
|
5 007
|
4 574
|
1 805
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
2
|
2
|
0
|
9
|
(1 193)
|
(2 691)
|
(3 331)
|
(3 620)
|
(2 465)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(31)
|
(69)
|
(69)
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
(57)
|
(49)
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(7 590)
|
(7 589)
|
(7 572)
|
(7 574)
|
(22)
|
(28)
|
(29)
|
(60)
|
(38)
|
(82)
|
(88)
|
0
|
71
|
74
|
80
|
135
|
175
|
139
|
(45)
|
(88)
|
|
| Pre-Tax Income |
(55)
N/A
|
(35)
+36%
|
(34)
+3%
|
(60)
-74%
|
91
N/A
|
(2 315)
N/A
|
(800)
+65%
|
1 280
N/A
|
1 910
+49%
|
5 084
+166%
|
5 411
+6%
|
4 606
-15%
|
1 668
-64%
|
11 088
+565%
|
14 711
+33%
|
10 594
-28%
|
10 755
+2%
|
1 738
-84%
|
(2 559)
N/A
|
2 369
N/A
|
4 342
+83%
|
879
-80%
|
642
-27%
|
(1 433)
N/A
|
(5 121)
-257%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
14
|
2
|
0
|
2
|
(3)
|
(1 001)
|
(1 235)
|
(1 558)
|
(1 646)
|
(1 046)
|
(1 156)
|
(1 027)
|
(242)
|
(2 210)
|
(2 616)
|
(1 227)
|
(1 206)
|
2 954
|
3 509
|
2 284
|
1 293
|
(342)
|
(323)
|
(303)
|
790
|
|
| Income from Continuing Operations |
(41)
|
(34)
|
(34)
|
(58)
|
87
|
(3 317)
|
(2 035)
|
(277)
|
264
|
4 038
|
4 255
|
3 580
|
1 426
|
8 877
|
12 096
|
9 366
|
9 548
|
4 692
|
950
|
4 654
|
5 636
|
538
|
319
|
(1 737)
|
(4 332)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
95
|
177
|
71
|
117
|
22
|
(53)
|
132
|
402
|
701
|
956
|
1 199
|
1 123
|
961
|
712
|
|
| Net Income (Common) |
(41)
N/A
|
(34)
+18%
|
(34)
-1%
|
(58)
-69%
|
87
N/A
|
(3 317)
N/A
|
(2 035)
+39%
|
(277)
+86%
|
264
N/A
|
4 038
+1 429%
|
4 255
+5%
|
3 674
-14%
|
1 603
-56%
|
8 948
+458%
|
12 212
+36%
|
9 389
-23%
|
9 496
+1%
|
4 824
-49%
|
1 351
-72%
|
5 355
+296%
|
6 592
+23%
|
1 736
-74%
|
1 442
-17%
|
(776)
N/A
|
(3 620)
-366%
|
|
| EPS (Diluted) |
-7.86
N/A
|
-6.44
+18%
|
-6.53
-1%
|
-10.81
-66%
|
16.58
N/A
|
-92.52
N/A
|
-49.04
+47%
|
-6.95
+86%
|
5.38
N/A
|
91.54
+1 601%
|
86.71
-5%
|
74.88
-14%
|
32.66
-56%
|
182.35
+458%
|
248.87
+36%
|
191.33
-23%
|
193.51
+1%
|
98.31
-49%
|
27.54
-72%
|
89.93
+227%
|
134.33
+49%
|
35.38
-74%
|
29.26
-17%
|
-15.53
N/A
|
-72.36
-366%
|
|
Switch to:
Switch to:
See Also
Discover More
